PR NEWSWIRE

Previous Stories

Razor Labs Launches DataMind AI™ 4.5, a Major Leap Forward in Predictive Maintenance and Fleet Management for Mining Operations

Dec 11 2025 - PR NewsWire

SYDNEY, Dec. 11, 2025 /PRNewswire/ — Razor Labs (TASE:RZR) announces the launch of DataMind AI™ 4.5, a powerful upgrade to…


Razor Labs Launches DataMind AI™ 4.5, a Major Leap Forward in Predictive Maintenance and Fleet Management for Mining Operations

Dec 11 2025 - PR NewsWire

SYDNEY, Dec. 11, 2025 /PRNewswire/ — Razor Labs (TASE:RZR) announces the launch of DataMind AI™ 4.5, a powerful upgrade to…


Razor Labs Launches DataMind AI™ 4.5, a Major Leap Forward in Predictive Maintenance and Fleet Management for Mining Operations

Dec 11 2025 - PR NewsWire

SYDNEY, Dec. 11, 2025 /PRNewswire/ — Razor Labs (TASE:RZR) announces the launch of DataMind AI™ 4.5, a powerful upgrade to…


Razor Labs Launches DataMind AI™ 4.5, a Major Leap Forward in Predictive Maintenance and Fleet Management for Mining Operations

Dec 11 2025 - PR NewsWire

SYDNEY, Dec. 11, 2025 /PRNewswire/ — Razor Labs (TASE:RZR) announces the launch of DataMind AI™ 4.5, a powerful upgrade to…


Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Dec 11 2025 - PR NewsWire

MELBOURNE, Australia and PALO ALTO, Calif., Dec. 11, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today…


Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Dec 11 2025 - PR NewsWire

MELBOURNE, Australia and PALO ALTO, Calif., Dec. 11, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today…


Ivalua Successfully Completes IRAP Assessment in Australia

Dec 11 2025 - PR NewsWire

IRAP further strengthens Ivalua’s global security credentials, reinforcing its role as the partner of choice for the most security-conscious organizations….


Ivalua Successfully Completes IRAP Assessment in Australia

Dec 11 2025 - PR NewsWire

IRAP further strengthens Ivalua’s global security credentials, reinforcing its role as the partner of choice for the most security-conscious organizations….


Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib’s Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Adva

Dec 11 2025 - PR NewsWire

First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters…


Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib’s Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Adva

Dec 11 2025 - PR NewsWire

First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters…


Analyse The Market From A Different Angle